Crinetics Approach

News Releases

News Releases

January 2, 2019
Crinetics Pharmaceuticals to Present at J.P. Morgan Healthcare Conference
SAN DIEGO , Jan. 02, 2019 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors, today announced that